Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lifemd Inc (LFMD)

Lifemd Inc (LFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 214,394
  • Shares Outstanding, K 43,312
  • Annual Sales, $ 152,550 K
  • Annual Income, $ -20,600 K
  • EBIT $ -19 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.38
  • Price/Sales 1.45
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 81.43% ( -3.97%)
  • Historical Volatility 74.52%
  • IV Percentile 43%
  • IV Rank 32.68%
  • IV High 124.77% on 08/07/24
  • IV Low 60.40% on 05/20/24
  • Put/Call Vol Ratio 5.74
  • Today's Volume 492
  • Volume Avg (30-Day) 449
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 11,464
  • Open Int (30-Day) 10,547

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.03
  • Low Estimate -0.08
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +58.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.54 +15.20%
on 12/19/24
6.52 -19.79%
on 12/03/24
-1.31 (-20.03%)
since 12/02/24
3-Month
3.99 +31.08%
on 10/30/24
7.54 -30.64%
on 11/13/24
+0.07 (+1.36%)
since 10/02/24
52-Week
3.99 +31.08%
on 10/30/24
12.88 -59.39%
on 05/07/24
-3.20 (-37.96%)
since 01/02/24

Most Recent Stories

More News
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LFMDP : 22.80 (+0.22%)
LFMD : 5.23 (+5.66%)
HIMS Stock Surges 43% in a Month: Will the Uptrend Continue Further?

Hims & Hers Health, Inc. HIMS has emerged as a transformative player in the personalized healthcare market, showcasing robust growth in 2024. Shares of the company have risen 43% in the past month, significantly...

LFMD : 5.23 (+5.66%)
TDOC : 9.52 (+4.73%)
HIMS : 25.20 (+4.22%)
AMWL : 7.04 (-2.90%)
LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution

LFMDP : 22.80 (+0.22%)
LFMD : 5.23 (+5.66%)
LifeMD to Participate in Three Investor Conferences During November

LFMDP : 22.80 (+0.22%)
LFMD : 5.23 (+5.66%)
LifeMD Reports Third Quarter 2024 Results

LFMDP : 22.80 (+0.22%)
LFMD : 5.23 (+5.66%)
LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency

LFMDP : 22.80 (+0.22%)
LFMD : 5.23 (+5.66%)
LifeMD Shares Decline Even After the Launch of Testosterone Therapy

LifeMD, Inc.’s LFMD Rex MD has launched TestoRx, a direct-to-consumer hormone therapy telehealth service. TestoRx provides an initial consultation with blood tests to pre-screen patients, offering both...

LFMD : 5.23 (+5.66%)
AVAH : 4.51 (-1.31%)
RDNT : 70.15 (+0.44%)
ADUS : 124.26 (-0.87%)
LifeMD® to Report Third Quarter 2024 Financial Results on November 7

LFMDP : 22.80 (+0.22%)
LFMD : 5.23 (+5.66%)
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering

LFMDP : 22.80 (+0.22%)
LFMD : 5.23 (+5.66%)
LifeMD, Inc. to Present at the June 1st Virtual Investor Summit

New York, New York--(Newsfile Corp. - May 23, 2023) - LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the virtual...

LFMD : 5.23 (+5.66%)

Business Summary

LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer...

See More

Key Turning Points

3rd Resistance Point 5.79
2nd Resistance Point 5.58
1st Resistance Point 5.40
Last Price 5.23
1st Support Level 5.02
2nd Support Level 4.80
3rd Support Level 4.63

See More

52-Week High 12.88
Fibonacci 61.8% 9.48
Fibonacci 50% 8.44
Fibonacci 38.2% 7.39
Last Price 5.23
52-Week Low 3.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar